跳至主要内容
临床试验/CTRI/2013/12/004218
CTRI/2013/12/004218Other未知

Gaucher Disease Outcome Survey (GOS) - GOS

Shire Human Genetic Therapies Inc0 个研究点目标入组 500 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients of any age or gender with confirmed diagnosis (biochemical and/or genetic) of Gaucher disease.
  • 2. Written informed consent obtained from the patient, and/or patientâ??s parent(s), and/or legal representative. Assent, if old enough to grant, will be obtained from all patients under the age of 18 years

排除标准

  • 1. Patients currently enrolled in ongoing blinded or open-label clinical trials (drugs or devices) (includes all blinded trials).

研究者

相似试验

Survey of the Gaucher Disease Outcome to use the... | 临床试验